课题基金 / 基金详情

MYOCARDIAL ISCHEMIC INJURY--MODIFICATION BY DRUG THERAPY

MYOCARDIAL ISCHEMIC INJURY--MODIFICATION BY DRUG THERAPY
心肌缺血性损伤——通过药物治疗缓解
批准号:
2903582
负责人:
Muhammad Ashraf
金额:
$29.65万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1979
资助国家:
美国
项目状态:
已结题
起止时间:
1979-05-01 至 2004-06-30

项目摘要

项目成果

Muhammad Ashraf的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The overall objective of this proposal is to elucidate the mechanism of early and late preconditioning against lethal ischemia. Our major hypothesis is that a mild increase in intracellular Ca++ effected by experimental and pharmacological interventions is a strong trigger for preconditioning and protein kinase C is a major player in the signaling cascade leading to protection. The opening of mitochondrial KATP channel which is believed to be pivotal in protection is dependent on the activation of PKC by intracellular [Ca++]i increase. Mitochondria which occupy a third of total cellular volume and perform multifactorial functions play a significant role in the survival of myocytes in stress and ischemic conditions. Under immediate stress conditions, the opening of mitochondrial KATP channel maintains the cell integrity by regulation of Ca++ homeostasis and increased ATP synthesis while the delayed protection is mediated by augmented synthesis of antioxidants. Both cell cultures and intact hearts will be used. The specific aims are to: determine whether [Ca++]i fluctuations by oxidative stress elicit both early and late protection; whether [Ca++]i mediated activation of PKC is responsible for early and late PC; whether opening of mitochondrial KATP channel is important in protection in late PC; whether opening of mitochondrial KATP channel is dependent on PKC activation and its translocation to mitochondria during early and late PC; if early and late PC by [Ca++]i reduces cell injury by inhibiting apoptosis by regulating permeability transition; if late PC by [Ca++]i is due to synthesis of antioxidants which inhibits apoptosis. A wide range of multidisciplinary techniques, including biochemistry, cell biology, molecular biology, electron microscopy, immunocytochemistry and pharmacological approaches will be used to integrate the information at the cell level with the function at the organ level. This investigation will produce important new insights into the molecular mechanisms of preconditioning and will have important implications for designing therapeutic interventions based on the unique endogenous adaptive responses by the myocardium.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Innovative Approaches to Treat Duchenne Muscular Dystrophy Using iPSC-Derived Muscle Progenitors
  • 批准号:
    9687673
  • 项目类别:
  • 资助金额:
    $51.54万
  • 财政年份:
    2016
  • 负责人:
    Muhammad Ashraf
  • 依托单位:
Innovative Approaches to Treat Duchenne Muscular Dystrophy Using iPSC-Derived Muscle Progenitors
  • 批准号:
    9232058
  • 项目类别:
  • 资助金额:
    $54.18万
  • 财政年份:
    2016
  • 负责人:
    Muhammad Ashraf
  • 依托单位:
Notch1/miR-322 Axis in Stem Cell Mediated Vascular Repair
  • 批准号:
    9332457
  • 项目类别:
  • 资助金额:
    $62.14万
  • 财政年份:
    2016
  • 负责人:
    Muhammad Ashraf
  • 依托单位:
Notch1/miR-322 Axis in Stem Cell Mediated Vascular Repair
  • 批准号:
    9478676
  • 项目类别:
  • 资助金额:
    $62.14万
  • 财政年份:
    2016
  • 负责人:
    Muhammad Ashraf
  • 依托单位:
海外基金